Share of new oncology medicines available in Europe in 2023, by country

Percentage of oncology medicines approved by the EMA available to patients in Europe as of 2023, by country

Loading statistic...
Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

April 2023



Survey time period

as of January 5, 2023

Supplementary notes

46 oncology medicines were approved by the European Medicines Agency between 2018 and 2021.
In most countries availability equates to granting of access to the reimbursement list, except in DK, FI, LU. NO, SE some hospital products are not covered by the general reimbursement scheme.
* Country did not complete a full dataset and therefore availability may be unrepresentative.
** In Spain, the WAIT analysis does not identify those medicinal products being accessible earlier in conformity with Spain's Royal Decree 1015/2009 relating to Medicines in Special Situations.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry


About the region


Selected statistics


Other regions


Related statistics


Further related statistics

Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.